StockDuty ← Dashboard Jul 16, 2026 09:37 PM ET
CatalystDerivatives

KALSHI TO ALLOW BETS ON CLINICAL TRIALS, FDA DECISIONS - REUTERS - GNEWS

Unique catalysts of clinical trials and FDA decisions drive speculative interest.

Unique catalysts of clinical trials and FDA decisions drive speculative interest.
Unique catalysts of clinical trials and FDA decisions drive speculative interest. — impact context not separately stored; see What changed.
Sources